Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-01-16

FDA Approved: MIRTAZAPINE — Supplemental Application (Aurolife Pharma LLC)

View source ↗

Summary

FDA approved a supplemental application for Mirtazapine from Aurolife Pharma LLC (ANDA 076921). The action reflects a regulatory approval related to this generi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • mirtazapine (mirtazapine)

Snippet

SUPPL AP for MIRTAZAPINE (MIRTAZAPINE)